Medtech · Take-over
What acquirers test
As R&D director of a medical device company, presented and defended the technology, IP and regulatory position in take-over discussions with interested parties.
For investors
Will it scale? Will it sell?
An independent technical view before the investment decision, and support after it. Built on years at the table where technology, operations and investment decisions meet.
Four lenses on every investment case
Market
- Which cheaper or established alternatives does the customer already have?
- What does it take for a conservative customer to switch?
- Is the value proposition proven with paying customers, or assumed?
Scale-up
- What changes between pilot and first commercial plant: diffusion, heat transfer, separation, fouling?
- Which data are missing to design the first plant?
- Are safety margins and permitting realistic for the planned scale?
Supply chain
- Is the starting material produced today at the volume the plant needs?
- How many suppliers exist, and how stable are price and quality?
- Which critical equipment has long lead times or a single source?
Economics
- How mature is the CAPEX estimate, and what is the contingency based on?
- Do unit costs hold at realistic yields and uptime?
- What does it really cost to get from pilot to first commercial plant?
Services
01
Technical due diligence
Assessment of the technology and the plan to scale it, along the four lenses, plus process safety, permitting, IP position and team capability.
02
Exit and take-over readiness
Preparing or assessing the technical, IP and regulatory story an acquirer will test, from either side of the table.
03
Post-investment technical support
Monitoring technical milestones and acting as technical sparring partner for the board after the investment.
How an assignment runs
- 1. Intake callThe investment question, the timeline and the documents available.
- 2. Scope and quoteA fixed scope and price, agreed before work starts.
- 3. AssessmentData room review, site or lab visit, interviews with the team. Typically a few weeks.
- 4. ReportA written report with a verdict per lens, red flags and conditions for investment.
- 5. DebriefDiscussion of the findings with the investment team.
What the report contains
- A verdict per lens: market, scale-up, supply chain, economics
- Red flags and how serious they are
- Conditions for investment and suggested milestones
- What it takes to get to the first commercial plant
Selected cases
All cases →Equipment · Scale-up
From €5M to €50M
Supporting an inventor-founder in growing an equipment company for separation and drying of biomaterials from €5M to €50M.
Chemicals · Commercialisation
From in-house department to third-party business
Turned the in-house safety department into a business serving third-party customers and generating profit.
Independence
RAES Solutions does not accept assignments that could harm current or former employers or clients. Confidential information from previous roles is never used. Current roles are disclosed before any engagement.
Evaluating a technology investment?
A short call is the quickest way to see whether there is a fit.